90160130 - SINTBILO

Information

• Trademark
• 90160130

• Source

• Serial Number

  90160130

• Registration Number

  6489680

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  September 04, 2020
  3 years ago

• Registration Date

  September 21, 2021
  2 years ago

• Transaction Date

  September 21, 2021
  2 years ago

• Status Date

  September 21, 2021
  2 years ago

• Published for Opposition Date

  July 06, 2021
  2 years ago

• Location Date

  September 21, 2021
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  WHITE, TRAVIS WILLIAM

• Attorney Name

  Anessa Owen Kramer

  Law Office Assigned Location Code

  N80

• Owners

  • Innovent Biologics (Suzhou) Co., Ltd.

Case File Statements

• DM0000: The mark consists of the word "SINTBILO" in stylized font.
• GS0051: Pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; dietetic foods adapted for medical use; biological preparations for veterinary purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer and antivirals; diagnostic preparations for medical purposes

Case File Event Statements

• 9/21/2021 - 2 years ago

  19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/6/2021 - 2 years ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/6/2021 - 2 years ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/16/2021 - 3 years ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/1/2021 - 3 years ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/1/2021 - 3 years ago

  14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 6/1/2021 - 3 years ago

  13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/1/2021 - 3 years ago

  12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 6/1/2021 - 3 years ago

  11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/26/2021 - 3 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/26/2021 - 3 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/25/2021 - 3 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 2/22/2021 - 3 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/20/2021 - 3 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/20/2021 - 3 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/20/2021 - 3 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/12/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/9/2020 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 9/8/2020 - 3 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP